Order by Supreme Court of the United States confirms SmartGene’s success invalidating patents which threatened the practice of personalized medicine.

Poster presented at the Medical Biodefense Conference in Munich, Germany.

SmartGene becomes an official Service Provider to the Public Hospital Laboratories AP-HP in Paris, France.

SmartGene Inc. announces the availability of curated reference databases to aid in sequence-based identification of Nocardia species.

SmartGene and the Institute of Medical Microbiology, University of Zurich expand their collaboration to address the sequence-based validation of mass spectrometry platforms for clinical microbiology.

SmartGene's Services for faster, more precise identification of Bacteria and Fungi to be used by the Johns Hopkins Hospital.

SmartGene has recently signed a contract to develop a data-analysis and data-management system dedicated to the typing of Campylobacter species as part of a European Union Consortium project called BIOTRACER.

SmartGene Inc. and LabCorp enter into a collaboration for faster, more precise identification of Bacteria and Fungi by sequence analysis.